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Received March 31, 2014; accepted October 14, 2014AbstractExperimental autoimmune uveitis, a well-established model for human uveitis, is similar to human uveitis in many pathological features.
Studies concerning the mechanisms of experimental autoimmune uveitis would cast a light on the pathogenesis of human uveitis as well as the
search for more effective therapeutic agents. The cellular components of innate immunity include natural killer cells, gamma delta T
lymphocytes, antigen-presenting dendritic cells, phagocytic macrophages, and granulocytes. It is believed that T cells are central in the
generation of human uveitis. It has already become clear that CD4þ effecter cells that predominantly produce interleukin-17 (the so-called Th17
cells) may play an important role in uveitis. In addition, the occurrence and recurrence of uveitis depends on a complex interplay between the
elements of innate and adaptive immunity.
Copyright © 2015 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Uveitis, an inflammatory disease that potentially causes
blindness, presents a therapeutic challenge for all
ophthalmologists. Knowledge of the classification and
etiology of uveitis is important for the diagnosis and treatment
of the disorder. The human body is often in routine contact
with all kinds of pathogens, but it does not become diseased or
ill, which is reflected in innate immunity. The adaptive
immunity, distinguishing the foreign pathogens from the body,
is able to maintain the integrity of the immune system and
make appropriate responses to the peripheral environment.
Dysfunction of innate and adaptive immune systems can resultConflicts of interest: The authors declare that there are no conflicts of interest
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1726-4901/Copyright © 2015 Elsevier Taiwan LLC and the Chinese Medical Assin unregulated, inappropriate, and detrimental autoimmune
disease including uveitis. In this article, we will review an
animal model of uveitis, the different roles of innate immunity
and adaptive immunity, together with their interplay in the
pathogenesis of uveitis.2. Experimental autoimmune uveitis model is an effective
and suggestive means for uveitis research
Uveitis, a common cause of visual impairment and
blindness, is an autoimmune disorder predominantly mediated
by T helper cells,1 and is associated with chronic and recurrent
ocular complications.2 The annual incidence rate of uveitis
varies between 17 cases and 52 cases per 100,000, and its
prevalence varies between 69 cases and 204 cases per 100,000
populations.3 In developed countries, uveitis affects
approximately 200 per 100,000 in the population, and uveitis
and its complications account for up to 35% of severe visual
impairment.4 Uveitis is the third leading cause of blindnessociation. All rights reserved.
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persons per year.5 In less developed countries, uveitis and its
complications are even more common, affecting an estimated
714 per 100,000 and contributing to 25% of blindness.4
Consequently, it poses a heavy burden on society and the
family.6
According to the different anatomic locations of the
inflammation, uveitis is classified as anterior uveitis, inter-
mediate uveitis, posterior uveitis, and panuveitis. Anterior
uveitis is the most common type, constituting 50e92% of all
types in Western countries and 28e50% in Asia.7 Intermediate
uveitis is primarily idiopathic and bilateral in childhood and
adult groups, and accounts for 6% of all uveitis cases observed
over a period of 16 years.8 Posterior uveitis is thought to
comprise approximately 5% of all uveitis entities.4 Acute
anterior uveitis is a common ocular inflammatory disease that
can cause severe visual impairment. In addition to recurrence,
acute anterior uveitis may lead to sight-threatening compli-
cations such as cataract, macular edema, and glaucoma.9 The
intermediate and posterior uveitis are associated with a group
of ocular disorders characterized by inflammation of the
choroid, retina, retinal vessels, vitreous, or ciliary body that
may occur in isolation, as part of a panuveitis, or in
conjunction with systemic disease.10
The vast majority of cases of uveitis are caused by auto-
immune response. There are animal models of uveitis (Table
1)20,52,53. However, because human pathology specimens
have been unavailable, experimental autoimmune uveitis
(EAU) has been established in vivo.11 EAU is a mature animal
model that can mimic human uveitis.12 It can be manipulated
by immunization with several retinal autoantigens, of which
retinal S-antigen (S-Ag) and interphotoreceptor retinoid
binding protein (IRBP) are featured (Tables 2 and 3)15,54e61.
Unfortunately, most of these models display an acute andTable 1
Major animal models of uveitis.
Animals and types of model Examples of models
Rat
Immunization with retinal
antigen in CFA or adoptive
transfer of T cells from immunized
donors to naïve recipients
Arrestin-induced model
in the Lewis ret. Many
other retinal and choroidal
(melanin) antigens are also
uveitogenic in Lewis rat
Mouse
Immunization of wild type mice
with ocular antigen in CFA or
adoptive transfer of immune cells
(or cell lines) from immunized
donors to naïve recipients
Spontaneous uveitis
EAU is induced in B10.RIII,
B10.A and C57BL/6 mice
with IRBP
T cell receptor transgenic
(R161H) mice in IRBP
Spontaneous uveitis in
Autoimmune Regulator-defici
mice directed at IRBP
CFA ¼ complete Freund's adjuvant; EAU ¼ experimental autoimmune uveitis; IRmonophasic disease course with spontaneous recovery, raising
questions about how well laboratory observations acquired
from such studies reflect the actual situation in the human
disease. Because recurrent uveitis poses the highest risk for
ocular complications in human disease that could cause
blindness, availability of a chronic and/or relapsing animal
model would be most helpful for dissecting the disease path-
ogenesis. A chronic recurrent uveitis model was induced in the
Lewis rat by adoptive transfer of T cells specific for IRBP
peptide (sequence of 1177e1191 of bovine IRBP protein,
R16).13,14 The disease is characterized by a chronic recurrent
pattern of uveitis, with an unpredictable frequency and dura-
tion of remission and relapses.14 The clinical symptoms star-
ted 3e5 days after transfer, and manifested in multiple
episodes, each lasting 1e7 days, followed by varying periods
of remission. Neither the duration of a single disease peak nor
the interval between episodes was predictable. In addition, the
right and left eyes of a single recipient often showed a
different rhythm of relapse, similar to the situation often seen
in the human disease. Given that a large number of transgenic
and knockout mice are available on the C57BL/6 background,
many studies have chosen to use the C57BL/6 mouse. Un-
fortunately, C57BL/6 mice only develop very weak EAU after
immunization with IRBP1e20. The induced disease occurred
at a low incidence with mild inflammation and a short duration
(average score of 0.5 out of maximal 4).15,16 The availability
of a reproducible model of uveitis in the C57BL/6 mouse is
particularly desirable. When T cells are isolated from the
immunized mice and adoptively transferred to a naïve C57BL/
6 mouse, the recipient develops a much more severe disease,
with an average score of 2e3 and duration of at least 60 days.
Similar to relapsing uveitis in Lewis rat, the incidence,
severity, and duration of disease were dependent on the
number and activation status of the injected T cells.17 InCharacters Refs
Was the major EAU model until the
mouse model was reported in 1988.
Nowadays, it is used by relatively
few groups. Generally, it mimics
the acute inflammation in anterior
52,53
TB in CFA provides innate signals
that polarize autoimmune lymphocytes
toward a proinflammatory phenotype.
Generally, it is a monophasic and
acute form of posterior uveitis;
transient anterior uveitis.
20,52,53
Spontaneous uveitis can start
at early age, and has minimal
anterior chamber involvement;
Generally, it is a chronic form
of posterior uveitis
20
ent
Spontaneous uveitis can start at
early age, and lacks anterior chamber
involvement. Generally, it is a
chronic form of posterior uveitis
20
BP ¼ interphotoreceptor retinoid binding protein; TB ¼ tuberculin.
Table 2
Retinal protein-derived peptides pathogenic for Lewis rats.
Source Position Amino acid sequence Refs
Bovine S-Ag 333e352 LTVSGL LGELTSSEVATEVP 54
Human S-Ag 181e200
(343e356)
VQHAPLEMGPQPRAEATWQF 55
54
Bovine IRBP 1177e1191 ADGSSWEGVGVVPDV 56
271e283
1158e1180
SQTWEGSGVLPCV
HVDDTDLYLTIPTARSVGAADGS
57
56
Human IRBP 521e540 YLLTSH RTATAAEEFAFLMQ 58
IRBP ¼ interphotoreceptor retinoid binding protein; S-Ag ¼ S-antigen.
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erate to severe spontaneous uveitis pathology by 2e3 months
of age.18 Autoimmune regulator deficient (AIRE/) mice can
induce EAU.19 Moreover, spontaneous mice can develop a
chronic-progressive disease, with a significant recovery of
visual function compared with IRBP-immunized B10.RIII
mice.20 The clinical heterogeneity of uveitis as well as the
finding of different pathological patterns suggest that uveitis
may be a spectrum of diseases that may represent different
pathological processes.
3. Pathogenesis of innate immunity in uveitis
Innate immunity is an evolutionarily conserved defense
mechanism capable of fighting a diverse threat of viral, pro-
karyotic, and eukaryotic parasites and pathogens in plants and
invertebrate animals.21 An innate immune system provides an
immediate host immune response to infectious agents and
relies on the expression of germline-encoded receptors for
their detection.22 A variety of circumstantial observations
suggest that the innate immune system is very important in the
development of uveitis.3.1. Natural killer T lymphocytes (natural killer T cells)Natural killer T (NKT) cells are a heterogeneous popula-
tion of unconventional T cells that express markers of NK
cells and T cell receptors (TCRs) and possess some of the
properties of NK cells and T cells, and are also a kind of
specific T lymphocyte subset. NKT cell subsets with different
functions exist in humans and mice, including classical (type
I) invariant and other CD1d-dependent (type II) NKT cells,
and also CD1d-independent (NKT-like) T cells.23 NKT cellsTable 3
Susceptibility of different mouse strains to IRBP-induced EAU.
Strain Position Amino acid sequence Refs
B10.RIII 161e180
171e190
SGIPYIISYLHPGNTILHVD
HPGNTILHVDTIYNRPSNTT
59
60
B10.A 201e216 ADKDVVVLTSSRTGGV 61
C57BL/6 1e20
461e480
651e670
GPTHLFQPSLVLDMAKVLLD
LRHNPGGPSSAVPLLLSYFQ
LAQGAYRTAVDLESLASQLT
15
60
60
EAU ¼ experimental autoimmune uveitis; IRBP ¼ interphotoreceptor retinoid
binding protein.are more prevalent in the liver than in other organs,
comprising up to 30% of the intrahepatic lymphocytes in
mice.24 The stability of NKT cells plays a role in the control
of various autoimmune diseases. Recently, it has been
observed that NKT cells present a wide range of responses in
their involvement in regulating the human immune system.25
NKT cells have also been shown to have the ability to resist
the virus and tumor, and contribute to the regulation of
autoimmune diseases.26 Innate immune cells, NKT cells, and
macrophages not only influence inflammatory tissue damage
but also participate in T lymphocyte responses to induce
uveitis.27 There is an increasing amount of evidence showing
that NKT cells are involved in the regulation of the adaptive
immune response as well.28 In our previous study, we
explored the diverse roles of NKT cells in the liver and spleen
and found that liver-derived NKT cells could efficiently
inhibit Th1 and Th17 differentiation, whereas the function of
spleen-derived NKT cells was less potent. Meanwhile, the
occurrence of the peak ratios of NKT cells/T cells in the
spleen and liver was markedly asynchronous after immuni-
zation. Moreover, different methods of immunization could
result in different immune responses in mice. Furthermore,
the memory response was also found in the generation of
NKT cells in mice when they received the same antigen.
These results indicated that there is diversity in the functional
roles of NKT cells in the spleen and liver in mice with
EAU.293.2. Gamma delta T lymphocytesGamma delta T cells were first described as peripheral
blood lymphocytes expressing CD3þ, a commonly used T cell
marker, but not alpha beta TCRs. Gamma delta T cells pos-
sessing surface receptors are a unique phenotype and the main
function of lymphocyte subsets in innate immunity.30 Studies
have shown that gamma delta T cells act to “bridge the gap”
between innate and adaptive immunity31 or to regulate the
intensity of the adaptive immune response.32 There is also
evidence that different gamma delta T cell subsets have
different immunoregulatory effects.33,34 It has been shown that
in vitro activation of IRBP-specific T cells from C57BL/6
mice immunized with an uveitogenic IRBP peptide
(IRBP1e20) under Th17-polarizing conditions is associated
with increased expansion of T cells expressing the gamma
delta TCR. It has also been shown that highly purified alpha
beta or gamma delta T cells from C57BL/6 mice immunized
with IRBP1e20 produced only small amounts of interleukin
(IL)-17 after exposure to the immunizing Ag in vitro, whereas
a mixture of the same T cells produced significantly increased
amounts of IL-17. IRBP-induced T cells from IRBP-
immunized TCR-delta/ mice on the C57BL/6 genetic
background produced significantly lower amounts of IL-17
than did wild-type C57BL/6 mice and had significantly
decreased EAU-inducing ability. However, reconstitution of
the TCR-delta/ mice prior to immunization with a small
number of gamma delta T cells from IRBP-immunized
C57BL/6 mice restored the disease-inducing capability of
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tion of IL-17þ T cells in the recipient mice. Our study suggests
that gamma delta T cells are important in the generation and
activation of IL-17-producing autoreactive T cells and play a
major role in the pathogenesis of EAU.35
There are some cells and proteins in the body that are
involved in uveitis of innate immunity, for example, dendritic
cells,36 macrophages,16 complement,37 and TLRs38 (Table
4)27,29,33,36e38.
4. Etiology of adaptive immunity in uveitis
The mechanism of adaptive immunity has added to the
human immune system a specific recognition of carbohy-
drates, lipids, pathogenic proteins, and nucleic acids in its
effort to mount an immune defense and defy their evasion
strategies and attack against the ever-growing pool of
disorders.21
The uveitogenic T cells that mediate EAU were commonly
assumed to be exclusively CD4þ. The involvement of both
CD4 and CD8 autoreactive T cells in autoimmune diseases
has been well established recently. Recent studies have also
shown that a specific autoreactive T cell subset that produces
IL-17, but not interferon (IFN)-g or IL-4, is crucially involved
in the pathogenesis of autoimmune diseases. We try to illus-
trate the uveitogenic role of CD8 and IL-17þ uveitogenic T
cells.4.1. CD8 uveitogenic T cellsCD4þ are commonly proposed to be exclusive in the
uveitogenic T cells that modulate EAU. Our data revealed that
even if all the long-term cultured uveitogenic T cell of rat linesTable 4
Function of innate immunity in uveitis.
Cells Functions Refs
NKT cells Different derived NKT cells exhibit
prominently inhibitory influence on
the development of EAU
29
Different derived NKT cells could
exert different immune responses to EAU
29
Possess diversity in the spleen and
liver in EAU mice
29
Gamma delta T
lymphocytes
In the generation and activation of
IL-17-producing autoreactive T cells
and play a major role in the
pathogenesis of EAU
33
Have a proinflammatory effect in EAU 33
Expressing Vg4 TCR segments in EAU 33
Macrophages Participant in T lymphocyte responses
to induce uveitis
27
Dendritic cells Activated dendritic cells into the retina
by local injury promoted the
pathogenesis of EAU
36
Complement Decrease the inflammatory response 37
TLRs Contribute to the pathogenesis of uveitis 38
EAU ¼ experimental autoimmune uveitis; IL ¼ interleukin; NKT ¼ natural
killer T; TCR ¼ T cell receptor; TLRs ¼ Toll-like receptors.particularly for R16 expressed CD4, as many as 40% of the
freshly prepared R16-specific uveitogenic T cells from Ag-
immunized rats were CD8þ alpha beta TCRþ. The CD8 T
cells were highly purified and antigen-specific CD8þ R16-
specific T cells that were capable of producing uveitis by
means of transfusion into naive rats. Furthermore, compared to
their CD4þ counterparts, CD8þ uveitogenic T cells were more
fully prepared to switch phenotype to or from
TCRCD8CD4 when they were activated in vivo or
in vitro.39
Autoreactive CD8 T cells were also abundant in B10.RIII
mice, an EAU-susceptible strain, immunized with the uveito-
genic peptide IRBP161e180.40 Different from CD4 autor-
eactive T cells, the growth factors produced by activated CD8
autoreactive T cells were rather limited.41 For this reason, the
activation and expansion CD8 T cell would be aborted in the
absence of exogenously supplied growth factor(s), whereas the
growth and expansion of triggered CD8 autoreactive T cells
could be supported by a series of cytokines. Besides the fac-
tors produced by activated CD4 autoreactive T cells, other
factors produced by nonlymphoid cells (e.g., IL-7, IL-15),
retinal pigment epithelial (RPE) cells, as well as unidentified
factors in the culture supernatants of astrocytes were capable
of supporting the CD8 autoreactive T cells as well. Even
though the response of CD8 T cell in vitro could be augmented
by several cytokines, different cytokines seem to act on
different CD8 subsets or activation/differentiation phases of
CD8 autoreactive T cells. For this reason, cytokines, such as
IL-7, were proposed to support the proliferation and survival
of CD8 IRBP-specific T cells, whereas others only had a
growth-promoting effect.
Additionally, a previous study, by which the role of the
CD8 IRBP-specific T cells in the etiology of EAU could be
further corroborated, demonstrated that the susceptibility of
the b2-microglobulin/ mouse to the induction of EAU by
adoptive transfer of IRBP-specific T cells from C57BL/6 mice
was substantially decreased.424.2. IL-17þ uveitogenic T cellsRecent investigations have shown that a specific autor-
eactive T cell subset that produces IL-17 instead of IFN-g and
IL-4, played a key role in the etiology of autoimmune disor-
ders, including experimental autoimmune encephalomyelitis,
rheumatoid arthritis, and other allergic diseases, especially in
the chronic phase.43e45 In order to determine the role of IL-
17þ T cells in the generation of EAU and the interrelationship
between previously characterized uveitogenic T cell subsets
and IL-17þ T cells, we investigated the involvement and the
pathologic function of IL-17þ T cells in EAU. By making a
comparison of the pathogenic effect between IL-17þ and
nonspecific IL-17þ T cells specific for the uveitogenic antigen,
the event whether IL-17 was expressed by CD4 autoreactive T
cells exclusively or by CD8 autoreactive T cells, which we
were even more interested in, was further determined. Our
data revealed that, in EAU, the capability of CD4 and CD8
autoreactive T cells were equal in expressing IL-17. IL-17
280 H.-S. Bi et al. / Journal of the Chinese Medical Association 78 (2015) 276e282would be preferentially expressed by IRBP-specific T cells
when they were expanded by IL-23, whereas IFN-g-express-
ing cells were dominant when the T cells were cultured with
IL-2. Both sets of expanded T cells were uveitogenic. The
results of the comparison between IL-17þ T cells elicited by
antigen-specific stimulation in vitro and those elicited by
antigen-nonspecific activation (anti-CD3 antibody) revealed
that only antigen-specific IL-17þ T cells were uveitogenic.
More interestingly, the activation of IL-17-producing T cells
were markedly enhanced by the ligation of TLRs both in vivo
and in vitro.46
IL-17þ T cells would accumulate in the inflamed eye in
uveitis patients, and the number of suchT cells usually correlated
with the severity of the induced disease. Thereafter, intraocular
injection of anti-IL-17 markedly attenuated the severity of dis-
ease, and the number of infiltrating cells in the eye was signifi-
cantly decreased in the treated mice. And the activated retinal
astrocytes (RACs), other than RPE, would contribute to the
increased proportion of intraocular IL-17þ T cells.47
Together with the IL-23/IL-17 basic study in EAU, the role
of IL-23 and IL-17 is also discussed in
VogteKoyanagieHarada syndrome during the clinical study
of uveitis. The expression of IL-23 and IL-17 are increased in
patients, and IL-23 can promote the production of IL-17 in
peripheral blood mononuclear cells. A previous study
demonstrated that the IL-23/IL-17 pathway might play a key
role in the etiology of VogteKoyanagieHarada syndrome, and
this result has been further corroborated by an investigation of
Behcet's disorder.48
5. Interplay of innate and adaptive immunity in uveitis
Many of the diseases that afflict mankind are now thought
to be the result of dysfunctional innate and/or adaptive im-
mune responses.49 In some cases, the adaptive immune ele-
ments restrain innate immune responses. In other cases, the
combination of innate and adaptive immunity maximizes the
host defense while minimizing collateral damage to the host
tissues. Innate immunity generates help signals in the
damaged tissues, whereas adaptive immunity provides specific
responses to the insult that directly attack the pathogenic
process or recruit other powerful innate effector cells that,
although not specific by themselves, can act specifically by
their selective recruitment.21 Little is actually known about
innate-adaptive connections.50 However, the mechanisms by
which the innate immune system instructs and directs adaptive
immune responses are becoming increasingly clear.51 In-
teractions between innate and adaptive immunity can result in
harmful immunologic responses.51 The nexus of the innate
and adaptive systems involves many secrets even now, and
both innate and adaptive immunologists are finally united in
their desire to uncover them, working across a gap that is ever
narrowing.50 It is clear from the discussion in this section that
further evaluation of the relationship between the innate and
the adaptive arms of the immune system will provide a
significantly deeper insight into the mechanisms of uveitis as
well as result in better therapeutic approaches.6. Future perspectives
In this article, we have introduced important components of
an animal model of uveitis. EAU is an excellent animal model
for studying the pathogenesis of autoimmune diseases. Better
understanding of the pathogenesis of uveitis may help clini-
cians manage patients with inflammatory ocular diseases, and
further enable different uveitis entities to be effectively
compared.
EAU is regarded as an acute, monophasic disease.
Although EAU models help to shed light on the mechanisms
driving human disease, it is impossible to comprehensively
imitate human uveitis. Therefore, it is necessary to establish a
far better model to mimic human uveitis. The role of Th17 and
IL-17 in the pathogenesis of uveitis remains undefined in some
aspects. The innate and adaptive immune systems form one
integrated defense network. The interplay between the two
systems will become more meaningful when their mechanisms
are identified completely. EAU has also served as a useful
template for novel therapeutic approaches. By focusing on
EAU, different pathogenesis points provide clinicians with
some valid therapeutic targets for human uveitis. However,
continuation of the study would allow us to obtain much-
needed information for designing new and better therapies
for control and cure of such diseases.
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